MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 341.85
+31.50 (10.15%)
At close: Dec 2, 2025
MINAPHARM Pharmaceuticals Revenue
MINAPHARM Pharmaceuticals had revenue of 1.50B EGP in the quarter ending September 30, 2025, a decrease of -0.78%. This brings the company's revenue in the last twelve months to 6.92B, up 56.56% year-over-year. In the year 2024, MINAPHARM Pharmaceuticals had annual revenue of 5.66B with 45.55% growth.
Revenue (ttm)
6.92B
Revenue Growth
+56.56%
P/S Ratio
0.58
Revenue / Employee
15.39M
Employees
450
Market Cap
4.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.66B | 1.77B | 45.55% |
| Dec 31, 2023 | 3.89B | 271.51M | 7.50% |
| Dec 31, 2022 | 3.62B | 615.19M | 20.47% |
| Dec 31, 2021 | 3.01B | 644.34M | 27.29% |
| Dec 31, 2020 | 2.36B | 309.95M | 15.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| El Sewedy Electric Company | 266.87B |
| Commercial International Bank Egypt (CIB) S.A.E. | 124.00B |
| Telecom Egypt Company | 101.94B |
| Talaat Moustafa Group Holding | 53.03B |
| Qatar National Bank | 50.63B |
| Egypt Aluminum | 43.18B |
| Eastern Company S.A.E | 37.38B |
| Misr Fertilizer Production Company | 25.16B |